The Role of Patient Advocacy Groups in Generic Drug Development

Patient advocacy groups are having a growing influence over the development of generic drugs in the pharmaceutical industry. Their efforts have helped raise awareness about specific diseases, influence policy, and facilitate resource allocation. They have also played key roles in research, regulatory approval, and ensuring access to innovative treatments. As the industry shifts towards patient-centric approaches, patient advocacy groups will play an even greater role in shaping drug development.